Corpus ID: 10325420

Phage therapy of staphylococcal infections (including MRSA) may be less expensive than antibiotic treatment.

@article{Midzybrodzki2007PhageTO,
  title={Phage therapy of staphylococcal infections (including MRSA) may be less expensive than antibiotic treatment.},
  author={R. Międzybrodzki and W. Fortuna and B. Weber-Dąbrowska and A. G{\'o}rski},
  journal={Postepy higieny i medycyny doswiadczalnej},
  year={2007},
  volume={61},
  pages={
          461-5
        }
}
  • R. Międzybrodzki, W. Fortuna, +1 author A. Górski
  • Published 2007
  • Medicine
  • Postepy higieny i medycyny doswiadczalnej
  • The current drama of antibiotic resistance has revived interest in phage therapy. In response to this challenge, a phage therapy center was established at our Institute in 2005 which accepts patients from Poland and abroad with antibiotic-resistant infections. We now present data showing that efficient phage therapy of staphylococcal infections is no longer a treatment of last resort (when all antibiotics fail), but allows for significant savings in the costs of healthcare. 
    74 Citations
    Is phage therapy acceptable in the immunocompromised host?
    • J. Borysowski, A. Górski
    • Biology, Medicine
    • International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
    • 2008
    • 57
    Physiology and Pathology of Multidrug-Resistant Bacteria: Phage-Related Therapy
    • PDF
    Facing Antibiotic Resistance: Staphylococcus aureus Phages as a Medical Tool
    • 65
    • PDF
    Methicillin-resistant Staphylococcus aureus: an update.
    • 50
    • PDF
    Clinical aspects of phage therapy.
    • 205
    Phage therapy for respiratory infections
    • 30
    Phage treatment of human infections
    • 536
    • PDF
    The next generation of bacteriophage therapy.
    • 246
    • PDF

    References

    SHOWING 1-10 OF 41 REFERENCES
    Bacteriophage therapy of bacterial infections: an update of our institute's experience.
    • 159
    • PDF
    Use of bacteriophage in the treatment of experimental animal bacteremia from imipenem-resistant Pseudomonas aeruginosa.
    • 85
    • PDF
    Clinical impact of vancomycin-resistant enterococci.
    • R. Patel
    • Biology, Medicine
    • The Journal of antimicrobial chemotherapy
    • 2003
    • 150
    • PDF
    Current and emerging serious Gram-positive infections.
    • F. Menichetti
    • Biology, Medicine
    • Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
    • 2005
    • 135
    Burden of Methicillin‐Resistant Staphylococcus aureus: Focus on Clinical and Economic Outcomes
    • 83
    Bacteriophage Therapy Rescues Mice Bacteremic from a Clinical Isolate of Vancomycin-Resistant Enterococcus faecium
    • 416
    • PDF
    Management of Staphylococcus aureus infections.
    • 62
    • PDF
    Clinical characteristics of linezolid-resistant Staphylococcus aureus infections.
    • 73